Kymera Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.3M | 57k | 40.20 |
| 2023-12-31 | $1.4M | 54k | 25.46 |
| 2023-09-30 | $745k | 54k | 13.90 |
| 2023-06-30 | $1.2M | 54k | 22.99 |
| 2023-03-31 | $1.9M | 64k | 29.63 |
| 2022-12-31 | $1.5M | 61k | 24.96 |
| 2022-09-30 | $1.3M | 60k | 21.77 |
| 2022-06-30 | $1.1M | 55k | 19.69 |
| 2022-03-31 | $1.5M | 36k | 42.31 |
| 2021-12-31 | $2.1M | 34k | 63.48 |
| 2021-09-30 | $2.0M | 33k | 58.73 |
| 2021-06-30 | $1.3M | 28k | 48.52 |
| 2021-03-31 | $444k | 11k | 38.89 |
| 2020-12-31 | $650k | 11k | 61.96 |